Close
4

Seqens Seqens

X

Company profile for CatalYm

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
CatalYm is developing innovative immunotherapies targeting Growth Differentiation Factor 15 (GDF-15) to transform the tumor microenvironment and to substantially improve treatment options for patients with cancer. By making tumors accessible and susceptible again for the patient‘s own immune system CatalYm has developed its approach to overcome major limitations of existing immunotherapies and to improve cancer patient survi...
CatalYm is developing innovative immunotherapies targeting Growth Differentiation Factor 15 (GDF-15) to transform the tumor microenvironment and to substantially improve treatment options for patients with cancer. By making tumors accessible and susceptible again for the patient‘s own immune system CatalYm has developed its approach to overcome major limitations of existing immunotherapies and to improve cancer patient survival and quality of life. CatalYm is led by an experienced management team of serial biotechnology entrepreneurs and backed by international venture capital investors.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
CatalYm
Germany Flag
Country
Country
Germany
Address
Address
Am Klopferspitz 19 82152 Martinsried, Planegg
Telephone
Telephone
+49 (0)89 2000 664 40
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY